George Tziras
Vorstandsvorsitzender bei SMALL PHARMA INC.
Vermögen: 447 982 $ am 30.04.2024
Profil
George Tziras is currently the Chief Executive Officer & Director at Small Pharma, Inc. He is also a Non-Executive Director at Small Pharma Ltd.
and the Director & Chief Business Officer at Cybin, Inc. Previously, he worked as the Chief Business Officer & Director at Unilock Capital Corp.
Mr. Tziras completed his undergraduate degree at the University of Oxford and his graduate degree at The Paul H.
Nitze School of Advanced International Studies.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYBIN, INC.
0,17% | 05.04.2024 | 1 294 747 ( 0,17% ) | 447 982 $ | 30.04.2024 |
Aktive Positionen von George Tziras
| Unternehmen | Position | Beginn |
|---|---|---|
| SMALL PHARMA INC. | Vorstandsvorsitzender | 20.07.2022 |
| CYBIN INC. | Direktor/Vorstandsmitglied | 23.10.2023 |
Small Pharma Ltd.
 Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Direktor/Vorstandsmitglied | 01.01.2015 |
Ehemalige bekannte Positionen von George Tziras
| Unternehmen | Position | Ende |
|---|---|---|
| SMALL PHARMA INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von George Tziras
| University of Oxford | Undergraduate Degree |
| The Paul H. Nitze School of Advanced International Studies | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SMALL PHARMA INC. | Retail Trade |
| CYBIN INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Small Pharma Ltd.
Small Pharma Ltd. Pharmaceuticals: MajorHealth Technology Small Pharma Ltd. operates as a pharmaceutical company that develops a rapid-acting antidepressant to treat patients with depression. The company was founded by Peter Rands in 2015 and is headquartered in London, the United Kingdom. | Health Technology |
Unilock Capital Corp.
 Unilock Capital Corp. Financial ConglomeratesFinance Unilock Capital Corp. is a development stage company, which engages in the identification and evaluation of assets or businesses with a view to completing a qualifying transaction. It intends to become a capital pool industry. The company was founded on January 23, 2018 and is headquartered in Vancouver, Canada. | Finance |
